ALK-Abello A/S (AKBLF)
36.10
0.00 (0.00%)
USD |
OTCM |
Jan 15, 16:00
ALK-Abello Market Cap: 7.998B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 253.81B |
| Genmab A/S | 20.82B |
| Ascendis Pharma A/S | 13.14B |
| Evaxion AS | 30.26M |
| IO Biotech, Inc. | 37.13M |
Market Cap Related Metrics
| PE Ratio | 48.96 |
| PS Ratio | 8.884 |
| PEG Ratio | 1.140 |
| Price to Book Value | 8.231 |
| Price to Free Cash Flow | 198.19 |
| Price | 36.10 |
| Earnings Yield | 2.04% |
| PEGY Ratio | 1.140 |
| Operating PE Ratio | 36.59 |
| Normalized PE Ratio | 48.96 |